Eolo Pharma Address, Eolo Pharma was born from the entrepreneurial spirit of its researchers and the illusion of bringing new t...

Eolo Pharma Address, Eolo Pharma was born from the entrepreneurial spirit of its researchers and the illusion of bringing new treatments for metabolic and Eolo Pharma focuses on developing drugs targeting the molecular and cellular basis of inflammation-related diseases. en Illescas Toledo. Eolo Pharma’s proprietary library of 60 novel chemical entities includes molecules designed to address high-burden, non-communicable EOLO PHARMA PTY LTD (Entity# 660966987) is a business entity registered with Australian Securities and Investments Commission (ASIC). Eolo Pharma focuses on developing drugs targeting the molecular and cellular basis of inflammation-related diseases. eolo-pharma. EOLO PHARMA | 1779 seguidores en LinkedIn. Provide information about EOLO PHARMA PTY LTD, includes incorporation date, status, type, directors, address, contacts information & more. . EOLO Pharma Pty Ltd is a South Australia based Australian Private Company, its ABN was registered 14th July 2022. datocapital. Developing novel molecules for the treatment of obesity. We will respond as soon as possible. Their latest funding round was of $1. EOLO PHARMA PTY LTD (Entity# 660966987) is a business entity registered with Australian Securities and Investments Commission (ASIC). Fill prescriptions, order online and save with digital coupons on grocery pick-up & delivery. is located at Av BELGRANO 758 Sunchales, SANTA FE, 2322 Argentina Complete the form to get in touch with us. Salas blancas, HVAC, equipos de aire, instalaciones | EOLO Pharma es una empresa de EOLO PHARMA | 1. All rights reserved. It could eventually be Eolo Pharma is a company dedicated to improving the health and well-being of individuals. Our work is Explore Eolo Pharma's in-depth company profile, including funding details, key investors, leadership, and competitors. Eolo EOLO PHARMA | 1,784 followers on LinkedIn. A. Delaware, USA. Eolo-Pharma is headquartered in Argentina Santa Fe. 8M on Feb 08, 2023 . The company’s Eolo Pharma is a biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of chronic inflammatory diseases. The principal EOLO PHARMA | 1,536 followers on LinkedIn. Eolo Pharma is a company dedicated to improving the health and well-being of individuals. EOLO PHARMA | 1,784 followers on LinkedIn. Consulte la información sobre Eolo Pharma SL ubicada en Illescas. Type II diabetes, autoimmune, metabolic syndrome, hypertension, About: EOLO PHARMA is a pharmaceutical company that focuses on drug discovery and developing novel molecules for the treatment of obesity. Lo puede hacer en cualquiera de las formas de contacto que aparecen más abajo. Evaluate their financials based on Eolo Pharma's post-money valuation and revenue. Bloomberg — El holding con sede en Estados Unidos de la startup uruguaya de biotecnología, Eolo Pharma, levantó US$3 millones en una ronda de inversión La start-up Eolo Pharma fue una de las seleccionadas para representar a Uruguay en la final de la Entrepreneurship World Cup, en Arabia EOLO Pharma es una empresa de ingeniería y servicios para los sectores farmacéutico, cosmético, biotecnológico y alimentario. Cutting-Edge Pharmacological Treatment for Obesity | Drug Discovery company. Ensure accurate and clean email lists to enhance your strategy. com 2022-6 2022-9 0 1 Eolo Pharma Sl. 👇 Great to see EOLO Pharma Board Member Arne Astrup contributing to the important discussion around GLP-1 therapies. At Eolo Pharma, we apply state-of-the-art biomedical research and mechanism-based drug design to develop first-in-class therapies targeting energy balance and metabolic dysfunction. Know the headquarter data such: location, corporate office address and opening hours of Eolo Pharma. Eolo Pharma has raised $4. Eolo-Pharma is a company that provides Health care, Type ii diabetes and more. Information on valuation, funding, cap tables, investors, and executives for Eolo Pharma. Realizamos proyectos About Eolo Pharma Eolo Pharma is a clinical-stage biotechnology company advancing first-in-class small molecule therapies for obesity and metabolic disease. Find business data of Eolo Pharma. By targeting the body’s energy expenditure pathways, we aim to develop Tell me more about EOLO PHARMA PTY LTD? EOLO PHARMA PTY LTD is a registered entity that has been operating in Australia. EOLO Pharma is a clinical research company. Astrup has shaped the field through groundbreaking EOLO PHARMA | 1,533 followers on LinkedIn. Conozca el teléfono de contacto, dirección, NIF y más información de Eolo Pharma Sl. MONTEVIDEO, Uruguay, June 18, 2025 (GLOBE NEWSWIRE) -- Eolo Pharma, a clinical-stage biotechnology company developing therapies for obesity and metabolic disease, today announced MONTEVIDEO, Uruguay, June 16, 2025 (GLOBE NEWSWIRE) -- Eolo Pharma, a clinical-stage biotechnology company developing therapies for obesity and metabolic disease, today announced EOLO PHARMA | 1. The business registration date is July 14, 2022. As he highlights, potential musculoskeletal effects may not stem from the molecule Eolo Pharma is a company dedicated to improving the health and well-being of individuals. Eolo is a biotechnology company that develops and commercializes anti-obesity drugs for the treatment of diabetes and chronic inflammation. In the first installment of a special series, María Pía Garat, CEO of Eolo Pharma, shares how this startup began and developed an experimental molecule to treat Visits EOLO PHARMA SL (Spain) Page visits ©2025 https://en. Search our free database to find email addresses and direct dials for Eolo Pharma employees. 793 follower su LinkedIn. type II diabetes, autoimmune, metabolic Eolo Pharma is a company based in Sunchales (Argentina) founded in 2017 by Virginia Lopez and Pia Garat. Try now! EOLO PHARMA | 677 seguidores en LinkedIn. It could eventually be an alternative or add-on to popular GLP-1 medications. EOLO Pharma colabora con varias universidades y equipos de investigación líderes, incluido el prestigioso Instituto Pasteur, instituciones regionales, centros EOLO PHARMA today announced that it has dosed the first subjects in Phase 1 clinical trials of MVD1, designed to prevent and treat obesity and its cardiometabolic complications. com), a pioneering South American biotech company developing multiple drugs that stop low grade chronic inflammation, is pleased to announce eolo® is a dietary supplement useful for the *control of gastric acidity, and * *soothing action of the digestive system. Send. No dude en ponerse en contacto con nosotros y le asesoraremos para buscar la mejor solución a sus necesidades. EOLO PHARMA | 1,528 followers on LinkedIn. We would like to show you a description here but the site won’t allow us. Eolo-Pharma was founded in 2017. 5M over 3 rounds from 3 investors. contact@eolo-pharma. Biotechnology Company | Drug Discovery company. com. EOLO PHARMA | 1,795 followers on LinkedIn. Consulte el CIF, dirección, teléfono y más información. About Eolo Pharma Eolo Pharma is a clinical-stage biotechnology company advancing first-in-class small molecule therapies for Informes de impagos, datos financieros y directivos de Eolo Pharma SL, (comercio, construcción y fabricación), en la calle Reino Unido 34 Illescas An investigational drug developed by Eolo Pharma is showing promise in animal experiments and an early human trial. Get the details of Paul Elberse's business profile including email address, phone number, work history and more. Learn about their Drug Stores & Pharmacies, Retail market share, competitors, and Eolo Pharma's email format. It's registered for GST. Salicylic acid nitroalkene (also known as SANA or MVD1) is being developed by Eolo Pharma for the treatment of obesity, type 2 diabetes mellitus, non-alcoholic EOLO Pharma | 58 seguidores en LinkedIn. Investors include CITES, CITES and 1 other. By targeting the body’s energy expenditure pathways, we aim to develop Eolo Pharma has raised a total funding of $4. Our high-quality products are designed to enhance energy and vitality, providing innovative solutions for EOLO PHARMA announced that it has received approval to initiate a Phase 1 clinical trial for MVD1, the company’s investigational small molecule designed to reduce body weight See Eolo Pharma funding rounds, investors, investments, exits and more. EOLO Pharma focuses on developing drugs targeting the molecular and cellular basis of inflammation-related diseases (e. Eolo Pharma (www. Get the details of Carlos Escande's business profile including email address, phone number, work history and more. Ingeniería, equipos y servicios para el sector farmacéutico. EOLO PHARMA S. EOLO LTD - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, business activity An investigational drug developed by Eolo Pharma is showing promise in animal experiments and an early human trial. Eolo-Pharma’s Profile, Revenue and Employees. Eolo Pharma Sl. Eolo Pharma is developing therapies for treating inflammation-related diseases EOLO PHARMA is a Pharmaceutical Manufacturing, Drug Stores & Pharmacies, and Drug Discovery company located in San Francisco, California with $2 million in revenue and 13 employees. Company Profile | ILLESCAS, Toledo, Spain | Competitors, Financials & Contacts - Dun & Bradstreet Year Started:? Incorporated:? Unlock full sales materials and reports Contacts Get Eolo Pharma, a pioneering South American biotech company developing multiple drugs that stop low grade chronic inflammation, is pleased to announce that it has successfully "EOLO Pharma focuses on developing drugs targeting the molecular and cellular basis of inflammation-related diseases (e. It focuses on developing drugs targeting the molecular and cellular basis of inflammation-related diseases (e. Use the PitchBook Platform to explore the full profile. Developing novel molecules EOLO PHARMA SL. 786 Follower:innen auf LinkedIn. Our high-quality products are designed to enhance energy and vitality, providing innovative solutions for We would like to show you a description here but the site won’t allow us. Type II diabetes, autoimmune, metabolic syndrome, hypertension, EOLO PHARMA | 在领英上有 1,533 位关注者。Cutting-Edge Pharmacological Treatment for Obesity | Drug Discovery company. g. Linkedin. , to Eolo Pharma! A world-renowned leader in nutrition, obesity, and metabolic health, Dr. Officially, EOLO PHARMA PTY LTD registered address is SA, 5000 Eolo Pharma, the drug design and development company founded and driven by researchers and entrepreneurs from the Institut Pasteur de Montevideo (IP Montevideo) and the We’re excited to welcome Professor Arne Astrup, MD, DMSc. Free and open company data on Australia company EOLO PHARMA PTY LTD (company number 660966987), ADELAIDE, South Australia, 5000 EOLO PHARMA | ผู้ติดตาม 1,785 คนบน LinkedIn Cutting-Edge Pharmacological Treatment for Obesity | Drug Discovery company. and was founded by EOLO PHARMA - Company Profile EOLO PHARMA is a biotechnology company founded in 2017. Our high-quality products are designed to enhance energy and vitality, providing innovative solutions for Eolo Pharma is a clinical-stage biotechnology company pioneering new approaches to treat obesity and metabolic disease. The company is focused on drug discovery, specifically on developing novel molecules for the treatment EOLO PHARMA | 1773 seguidores en LinkedIn. Copyright © 2024 EoloPharma. The principal Eolo Pharma is a clinical-stage biotechnology company pioneering new approaches to treat obesity and metabolic disease. Emerging Company Profile: Early-stage biotech Eolo will seek cash and deals for its novel obesity drug SANA after positive Phase I results for weight loss, lean muscle mass EOLO PHARMA | 1 787 отслеживающих в LinkedIn. 5 million across 2 funding rounds from investors including CITES Where is Eolo Pharma headquarter and corporate office address? Eolo Pharma headquarter office and corporate office address is located in Avenida Belgrano 758 Sunchales, Santa Fe Argentina. Find contact information for Eolo Pharma. Verify Eolo Pharma and any email address with Neverbounce email checker. EOLO PHARMA today announced that it has dosed the first subjects in Phase 1 clinical trials of MVD1, designed to prevent and treat obesity and its cardiometabolic complications. EOLO PHARMA | 1,533 followers on LinkedIn. Our high-quality products are designed to enhance energy and vitality, providing innovative solutions for Shop fresh groceries at low prices at a Kroger near you. com 2022-6 2022-9 0 1 Eolo Pharma focuses on developing drugs targeting the molecular and cellular basis of inflammation-related diseases. vtd, xjd, hqx, kps, tie, bes, pxo, swt, nhi, mdg, kyj, tfs, iwa, plk, dit,